On June 25, 2025, LYRA ETK hosted the Digital Dentistry Society (DDS) at its headquarters in Sallanches for a day of exchange and discussion focused on innovation in implantology. A highlight of the day was the official presentation of the DDS “Product” Certification for iPhysio®, the digital healing abutment developed by LYRA ETK.
The certification was personally presented by Professor Francesco Mangano, President of the DDS, in the presence of Bernard Daymon (CEO of LYRA ETK), Cédric Lancieux (R&D Director), and Bénédicte Padovan (Marketing Director), who gave joint interviews on this occasion.
iPhysio® is a patented, digitally-coded healing abutment compatible with major implant platforms. It enables:
Its anatomical zirconia design and zirconia nitride coating contribute to greater precision and better tissue integration.
“It’s not just a digital tool – it actively supports healing, simplifies clinical steps, and improves reproducibility.”
— Cédric Lancieux, R&D Director
A clinical study published in late 2024 in the Journal of Dentistry, based on 103 patients, confirmed the effectiveness of iPhysio®, particularly in soft and hard tissue stability.
The event also included a full tour of the production facility, located in the Arve Valley, a key hub of French micromechanics. The DDS had the opportunity to witness LYRA ETK’s industrial expertise, quality standards, and complete control over its digital production chain.
For Bernard Daymon, iPhysio® embodies LYRA ETK’s vision: innovating to simplify clinical practice, while remaining accessible.
“To paraphrase Neil Armstrong, iPhysio® took many small preparation steps… but is now ready to be a giant leap in dental care.”
Founded in 1992, LYRA ETK’s mission has always been to democratize implantology with validated, effective, and open clinical solutions. Since joining a major French group in 2004, the company has strengthened its innovation capabilities through local production, R&D, and full digital workflow integration.
